Diabetic Retinopathy
Diabetic Retinopathy
In diabetic retinopathy, the back of the eye, where the image of what we see is formed, is damaged by very high blood sugar levels, and new and weak blood vessels can develop. Subsequently, because they are fragile, bleeding into the eye may occur. Unfortunately, this can result in vision loss. Early detection of the condition is essential for the fastest possible treatment. Scientists from Khoo Teck Puat Hospital and the National University of Singapore have discovered a molecule, osteopontin, that indicates the presence and severity of retinopathy.
Their work, reported in the journal Molecular Vision in February 2018, involved four hundred and forty-three participants. The researchers photographed the back of the participant's eyes, capturing the same image that doctors see when they examine their patients' eyes with an ophthalmoscope. Diabetic retinopathy was diagnosed in a total of one hundred and seventy-four participants, or 39 percent...the mean level of osteopontin was higher in participants with diabetic retinopathy than in those without eye problems.
higher levels of osteopontin were also observed in patients with more severe diseases.
From the above results, the researchers concluded that osteopontin may be useful in the diagnosis of diabetic retinopathy.
Diabetic retinopathy is the most common cause of blindness in adults aged 18 to 65. It can be prevented by following...
healthy diet, exercise a prescribed medication to keep blood sugar under control.
In some cases, vision can be restored by improving blood sugar control.
In other cases, drugs that inhibit vegetative endothelial growth factor (VEGF) can stop the disease's further development of retinopathy. The two most popular anti-VEGF drugs are…
Lucent is (ranibizumab) and
Avastin (bevacizumab).
Both of these drugs are applied to the eye.
.jpg)
Comments
Post a Comment